Late-onset neurologic Wilson’s disease: case series
Objective: To report the case series of patients with late-onset Wilson’s disease (WD) with predominantly neurological manifestation. Background: WD is a rare and treatable disorder…A Case of Concurrent Wilson Disease and Parkinson Disease
Objective: to present a case of concurrent Wilson disease and Parkinson disease. Background: Wilson disease (WD) is a rare autosomal recessive disease that typically manifests…A Curious Case of Copper de-Compensation
Objective: To describe the investigation and management of a patient with Wilson’s disease who experienced late-onset neurological deterioration despite continued treatment. Background: Wilson’s disease is…Wilson’s Disease : A Senegalese Series of Seven Patients Followed at Pikine National Hospital Centre (Dakar-Senegal)
Objective: The aim of this study is to describe the epidemiological, diagnostic, therapeutic and evolutionary characteristics of Wilson's disease and to highlight the diagnostic and…Real-life experience of switching from D-penicillamine to trientine tetrahydrochloride – a nationwide registry study
Objective: Our aim was to assess the efficacy and safety of trientine tetrahydrochloride (TETA4HCL) in a cohort of neurological Wilson's disease (WD) patients transitioned from…Transition from Zinc Salts to Trientine Tetrahydrochloride in Wilson Disease: Clinical and Biochemical Effects over Two Years – the ZICUP study
Objective: To assess the clinical and biochemical effects of transitioning from zinc salts (ZS) to trientine tetrahydrochloride (TETA4HCL) in Wilson disease (WD) patients over a…Prevalence of immune-mediated diseases in long-term chelator therapy in Wilson’s Disease
Objective: To determine the prevalence of concurrent immune-mediated diseases during copper chelation therapy in Wilson’s disease (WD). Background: Wilson’s disease is a neurometabolic autosomal recessive…Therapeutic challenges of long-standing chelator therapy in Wilson’s Disease
Objective: To determine the frequency of side effects of long-term copper chelation therapy in Wilson’s disease (WD). Background: WD is a neurometabolic autosomal recessive disorder…Free water neuro-imaging changes as the biomarker in new diagnosis of Wilson’s disease
Objective: The bi-tensor free water imaging may provide more specific information in detecting microstructural brain tissue alterations than conventional single tensor diffusion tensor imaging. The…D-penicillamine induced myasthenia gravis – the possible complication of Wilson’s disease treatment.
Objective: D-penicillamine (DPA) belongs to the most frequently used drugs in Wilson’s disease (WD) treatment. Despite the effectiveness in WD treatment, DPA could be involved in many…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.